Insider trades

Andrew J. Murphy, EVP of Regeneron Pharmaceuticals REGN, has filed 0 purchases and 55 sales on the open market. The latest trade was on 25/12/09.

Andrew J. Murphy

EVP Research
First filing
23/05/10
Trades
87 trades
Buys / sales
0 / 55
12-month net buying
No record
Last trade
25/12/09

Trading activity

Transactions

Trade type
REGN
Open-market sale10b5-1 plan24/08/1424/08/156,363 sh18 trades$1,153.15avg.$7,337,504.87−11.6%
REGN
Open-market sale10b5-1 plan24/03/1424/03/155,783 sh14 trades$956.47avg.$5,531,289.51−10.7%
REGN
Open-market sale10b5-1 plan23/12/0523/12/066,536 sh12 trades$817.44avg.$5,342,787.4−9.9%
REGN
Open-market sale10b5-1 plan23/11/1423/11/156,492 sh11 trades$799.17avg.$5,188,213.1−9.8%